Berger M, Schumacher F, Wollsching-Strobel M, Kroppen D, Stanzel S, Majorski D
J Med Case Rep. 2024; 18(1):392.
PMID: 39180090
PMC: 11344313.
DOI: 10.1186/s13256-024-04688-9.
Dias A, Groarke E, Hickstein D, Patel B
Ann Hematol. 2024; 103(11):4427-4436.
PMID: 39168911
PMC: 11535077.
DOI: 10.1007/s00277-024-05942-2.
Rasch M, Szabados F, Jensen J, Nielsen K, Hauge E, Troldborg A
RMD Open. 2024; 8(2).
PMID: 38967099
PMC: 9462080.
DOI: 10.1136/rmdopen-2022-002492.
Mertz P, Costedoat-Chalumeau N, Ferrada M, Moulis G, Mekinian A, Grayson P
Nat Rev Rheumatol. 2024; 20(6):347-360.
PMID: 38698240
DOI: 10.1038/s41584-024-01113-9.
Bellman P, Gonzalez-Lugo J, Shahzad M, Amin M, Khalid M, Suleman N
Front Oncol. 2024; 14:1383730.
PMID: 38665946
PMC: 11043578.
DOI: 10.3389/fonc.2024.1383730.
Deciphering the relationship between temperature and immunity.
Maloney E, Duffy D
Discov Immunol. 2024; 3(1):kyae001.
PMID: 38567294
PMC: 10917241.
DOI: 10.1093/discim/kyae001.
Clinical Manifestations in Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome: A Narrative Review.
Padureanu V, Marinas C, Bobirca A, Padureanu R, Patrascu S, Dascalu A
Cureus. 2024; 16(1):e53041.
PMID: 38410307
PMC: 10895688.
DOI: 10.7759/cureus.53041.
Autoimmunity and Autoinflammation: Relapsing Polychondritis and VEXAS Syndrome Challenge.
Cardoneanu A, Rezus I, Burlui A, Richter P, Bratoiu I, Mihai I
Int J Mol Sci. 2024; 25(4).
PMID: 38396936
PMC: 10889424.
DOI: 10.3390/ijms25042261.
VEXAS-Defining UBA1 Somatic Variants in 245,368 Diverse Individuals in the NIH All Of Us Cohort.
Corty R, Brogan J, Byram K, Springer J, Grayson P, Bick A
Arthritis Rheumatol. 2024; 76(6):942-948.
PMID: 38225170
PMC: 11410361.
DOI: 10.1002/art.42802.
VEXAS Syndrome-Diagnostic Clues for the Dermatologist and Gaps in Our Current Understanding: A Narrative Review.
Nicholson L, Cowen E, Beck D, Ferrada M, Madigan L
JID Innov. 2023; 4(1):100242.
PMID: 38130326
PMC: 10733701.
DOI: 10.1016/j.xjidi.2023.100242.
VEXAS syndrome: Current clinical, diagnostic and treatment approaches.
Kobak S
Intractable Rare Dis Res. 2023; 12(3):170-179.
PMID: 37662628
PMC: 10468411.
DOI: 10.5582/irdr.2023.01020.
VEXAS Syndrome-Review.
Zhang Y, Dong X, Wang H
Glob Med Genet. 2023; 10(3):133-143.
PMID: 37501758
PMC: 10370470.
DOI: 10.1055/s-0043-1770958.
Somatic mosaicism in inborn errors of immunity: Current knowledge, challenges, and future perspectives.
Aluri J, Cooper M
Semin Immunol. 2023; 67:101761.
PMID: 37062181
PMC: 11321052.
DOI: 10.1016/j.smim.2023.101761.
Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.
Beck D, Bodian D, Shah V, Mirshahi U, Kim J, Ding Y
JAMA. 2023; 329(4):318-324.
PMID: 36692560
PMC: 10408261.
DOI: 10.1001/jama.2022.24836.
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases.
Vitale A, Caggiano V, Bimonte A, Caroni F, Tosi G, Fabbiani A
Intern Emerg Med. 2023; 18(3):711-722.
PMID: 36662445
PMC: 10082120.
DOI: 10.1007/s11739-023-03193-z.
Autoinflammatory manifestations in adult patients.
Rodolfi S, Nasone I, Folci M, Selmi C, Brunetta E
Clin Exp Immunol. 2022; 210(3):295-308.
PMID: 36334040
PMC: 9985169.
DOI: 10.1093/cei/uxac098.
The First Korean Case of VEXAS Syndrome Caused by a Somatic Variant.
Yoon J, Lee S, Kim S, Kim M, Chang Y, Park J
Ann Lab Med. 2022; 43(2):217-220.
PMID: 36281520
PMC: 9618899.
DOI: 10.3343/alm.2023.43.2.217.
Vasculitis associated with VEXAS syndrome: A literature review.
Watanabe R, Kiji M, Hashimoto M
Front Med (Lausanne). 2022; 9:983939.
PMID: 36045928
PMC: 9420898.
DOI: 10.3389/fmed.2022.983939.
Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review.
Guerrero-Bermudez C, Cardona-Cardona A, Ariza-Parra E, Arostegui J, Mensa-Vilaro A, Yague J
Clin Rheumatol. 2022; 41(11):3565-3572.
PMID: 35986821
DOI: 10.1007/s10067-022-06338-1.
Update on VEXAS and role of allogeneic bone marrow transplant: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT.
Gurnari C, McLornan D
Bone Marrow Transplant. 2022; 57(11):1642-1648.
PMID: 35941354
DOI: 10.1038/s41409-022-01774-8.